1.68BMarket Cap
LossP/E TTM
RAPT Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-03-02The current valuation score of RAPT Therapeutics Inc is 6.76, ranking 224 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.99, which is -99.41% below the recent high of -0.03 and -139.73% above the recent low of -11.95.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.